German drug company Merck has halted life-saving cancer drug shipments to Greek public hospitals.
Its chief financial officer, Matthias Zachert told German paper Boersen-Zeitung on Saturday (3 November) that the crisis-struck country has not paid its bills.
"It only affects Greece, where we have been faced with many problems. It's just the one product," he said.
Reuters reports that the cancer-fighting drug is called Erbitux. While the medication will no longer be available...
Back our independent journalism by becoming a supporting member
Already a member? Login hereNikolaj joined EUobserver in 2012 and covers home affairs. He is originally from Denmark, but spent much of his life in France and in Belgium. He was awarded the King Baudouin Foundation grant for investigative journalism in 2010.
Nikolaj joined EUobserver in 2012 and covers home affairs. He is originally from Denmark, but spent much of his life in France and in Belgium. He was awarded the King Baudouin Foundation grant for investigative journalism in 2010.